Loading...
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
OBJECTIVE: This study assessed relative bioavailability of a new subcutaneous formulation, test (T) (dalteparin sodium 95000 IU/3.8 mL) with the branded product (R) in healthy subjects to meet the regulatory requirements of bioequivalence in the US. METHODS: This was an open label, randomized, singl...
Na minha lista:
| Udgivet i: | J Drug Assess |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Maney Publishing
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937650/ https://ncbi.nlm.nih.gov/pubmed/27536434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21556660.2013.781504 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|